Boston Financial Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $811K | Buy |
14,427
+3
| +0% | +$169 | 0.02% | 207 |
|
|
2024
Q3 | $983K | Hold |
14,424
| – | – | 0.03% | 195 |
|
|
2024
Q2 | $609K | Hold |
14,424
| – | – | 0.02% | 222 |
|
|
2024
Q1 | $996K | Hold |
14,424
| – | – | 0.03% | 197 |
|
|
2023
Q4 | $1.07M | Hold |
14,424
| – | – | 0.04% | 182 |
|
|
2023
Q3 | $984K | Hold |
14,424
| – | – | 0.04% | 177 |
|
|
2023
Q2 | $1.35M | Hold |
14,424
| – | – | 0.05% | 163 |
|
|
2023
Q1 | $978K | Sell |
14,424
-8
| -0.1% | -$542 | 0.04% | 177 |
|
|
2022
Q4 | $715K | Hold |
14,432
| – | – | 0.03% | 204 |
|
|
2022
Q3 | $469K | Sell |
14,432
-392
| -3% | -$12.7K | 0.02% | 219 |
|
|
2022
Q2 | $584K | Hold |
14,824
| – | – | 0.03% | 194 |
|
|
2022
Q1 | $1.04M | Buy |
14,824
+400
| +3% | +$28K | 0.04% | 161 |
|
|
2021
Q4 | $1.12M | Hold |
14,424
| – | – | 0.04% | 142 |
|
|
2021
Q3 | $1.38M | Hold |
14,424
| – | – | 0.06% | 127 |
|
|
2021
Q2 | $1.79M | Hold |
14,424
| – | – | 0.07% | 114 |
|
|
2021
Q1 | $1.9M | Hold |
14,424
| – | – | 0.08% | 103 |
|
|
2020
Q4 | $1.91M | Hold |
14,424
| – | – | 0.09% | 99 |
|
|
2020
Q3 | $1.47M | Buy |
14,424
+155
| +1% | +$15.8K | 0.07% | 110 |
|
|
2020
Q2 | $1.24M | Hold |
14,269
| – | – | 0.07% | 115 |
|
|
2020
Q1 | $828K | Buy |
14,269
+2,000
| +16% | +$116K | 0.05% | 128 |
|
|
2019
Q4 | $1.14M | Buy |
+12,269
| New | +$1.14M | 0.06% | 129 |
|
|
2019
Q1 | – | Sell |
-41,069
| Closed | -$2.59M | – | 264 |
|
|
2018
Q4 | $2.59M | Hold |
41,069
| – | – | 0.18% | 105 |
|
|
2018
Q3 | $3.24M | Sell |
41,069
-27,255
| -40% | -$2.15M | 0.19% | 107 |
|
|
2018
Q2 | $4.09M | Buy |
+68,324
| New | +$4.09M | 0.28% | 94 |
|